Quick Answer
Vicapsys Life Sciences, Inc. reported Operating Income Loss of -$1.05 million for the year ending 2023.
- Vicapsys Life Sciences, Inc. showed a decrease of -6.3% in Operating Income Loss from 2022 to 2023.
- This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
- XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2020 to 2023), Vicapsys Life Sciences, Inc.'s Operating Income Loss has declined by 36.7%.
- Historical annual values: Fiscal year 2023: -$1.05 million | Fiscal year 2022: -$984.8 thousand | Fiscal year 2021: -$336.9 thousand | Fiscal year 2020: -$765.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: